DE60216979D1 - Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon - Google Patents

Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon

Info

Publication number
DE60216979D1
DE60216979D1 DE60216979T DE60216979T DE60216979D1 DE 60216979 D1 DE60216979 D1 DE 60216979D1 DE 60216979 T DE60216979 T DE 60216979T DE 60216979 T DE60216979 T DE 60216979T DE 60216979 D1 DE60216979 D1 DE 60216979D1
Authority
DE
Germany
Prior art keywords
tetracos
apocynin
trans
synergistic composition
acidic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216979T
Other languages
English (en)
Other versions
DE60216979T2 (de
Inventor
Sukhdev Swami Handa
Parkash Suri
V N Gupta
Avtar Suri
Kumar Satti
Vikram Bhardwaj
Bupinder Singh
Krishan Chandan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Application granted granted Critical
Publication of DE60216979D1 publication Critical patent/DE60216979D1/de
Publication of DE60216979T2 publication Critical patent/DE60216979T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
DE60216979T 2002-03-25 2002-03-25 Synergistische hepatoprotektive Zusammensetzung aus trans-Tetracos-15-ensäure und Apocynin und Verwendung davon Expired - Lifetime DE60216979T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/001212 WO2003080081A2 (en) 2002-03-25 2002-03-25 Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof

Publications (2)

Publication Number Publication Date
DE60216979D1 true DE60216979D1 (de) 2007-02-01
DE60216979T2 DE60216979T2 (de) 2007-08-30

Family

ID=28053185

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216979T Expired - Lifetime DE60216979T2 (de) 2002-03-25 2002-03-25 Synergistische hepatoprotektive Zusammensetzung aus trans-Tetracos-15-ensäure und Apocynin und Verwendung davon

Country Status (7)

Country Link
EP (1) EP1509285B1 (de)
JP (1) JP4299147B2 (de)
CN (1) CN1269475C (de)
AT (1) ATE348648T1 (de)
AU (1) AU2002253445A1 (de)
DE (1) DE60216979T2 (de)
WO (1) WO2003080081A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1602926A1 (de) * 2004-06-04 2005-12-07 University of Geneva Neue Mittel und Verfahren zur Behandlung von Gehörverlust oder Tinnitus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999012539A1 (en) * 1997-09-10 1999-03-18 The Johns Hopkins University School Of Medicine The use of an nadph-oxidase inhibitor in the treatment of reperfusion injury
US6492429B1 (en) * 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
GB2368012A (en) * 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease

Also Published As

Publication number Publication date
JP4299147B2 (ja) 2009-07-22
WO2003080081A3 (en) 2004-12-23
WO2003080081A2 (en) 2003-10-02
JP2005526098A (ja) 2005-09-02
CN1625422A (zh) 2005-06-08
CN1269475C (zh) 2006-08-16
AU2002253445A1 (en) 2003-10-08
AU2002253445A8 (en) 2003-10-08
EP1509285A2 (de) 2005-03-02
ATE348648T1 (de) 2007-01-15
DE60216979T2 (de) 2007-08-30
EP1509285B1 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
DE602004018338D1 (de) Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
EA200501805A1 (ru) Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
DK1539166T3 (da) Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DE60330485D1 (de) Zur behandlung von diabetes
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
ATE430555T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
SE0001899D0 (sv) New compounds
EP1446136A4 (de) Curcuminoid-zusammensetzungen mit synergistischer hemmung der expression und/oder wirkung von cyclooxygenase-2
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
ATE419850T1 (de) Zusammensetzungen zur behandlung von diabetes die einen dp iv-inhibitoren und einen andere antidiabetikum enthalten
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
HRP20050103A2 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
ATE318606T1 (de) Zusammenstellungen zur prophylaxe und behandlung von allergien des typus i
DE60306934D1 (de) Verwendung von Nitrilenverbindungen als Arztneimittel
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
ATE348648T1 (de) Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon
SE0301883D0 (sv) New use II

Legal Events

Date Code Title Description
8364 No opposition during term of opposition